Martha Port

Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials

Li Shen Loo, Jessica Ailani, Jack Schim et al. · The Journal of Headache and Pain · 2019 · 43 citations · Full text

Medicine, Neurology, Pharmacotherapy +16

Galcanezumab in Patients with Multiple Previous Migraine Preventive Medication Category Failures: Results from the Open-Label Period of the CONQUER Trial

Uwe Reuter, Christian Lucas, David Doležil et al. · Advances in Therapy · 2021 · 37 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Changes in migraine interictal burden following treatment with galcanezumab: Results from a phase III randomized, placebo‐controlled study

Richard B. Lipton, Dawn C. Buse, Claire H. Sandoe et al. · Headache The Journal of Head and Face Pain · 2023 · 25 citations · Full text

Medicine, Neurology, Pharmacology +17

Effect of age on pharmacokinetics, efficacy, and safety of galcanezumab treatment in adult patients with migraine: results from six phase 2 and phase 3 randomized clinical trials

Virginia L. Stauffer, Ira Turner, Phebe Kemmer et al. · The Journal of Headache and Pain · 2020 · 17 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Does “wearing off” of efficacy occur in galcanezumab‐treated patients at the end of the monthly treatment cycle? Post hoc analyses of four phase III randomized trials

Jessica Ailani, Dulanji Kuruppu, Mallikarjuna Rettiganti et al. · Headache The Journal of Head and Face Pain · 2022 · 14 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16